Esophageal stents: When and how

Toufic Kachaamy, Rahul Pannala

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Esophageal stents are devices used to alleviate dysphagia and treat leaks and perforations. Successful esophageal stenting requires definition of the abnormal anatomy such as stricture length or location of the leak, proper stent selection and deployment. This requires detailed knowledge of characteristics of the currently available stents. Self-expanding metal stents whether fully or partially covered have become the mainstay of treatment of esophageal cancer-related dysphagia as they provide quick relief of symptoms and have a favorable safety and efficacy profile, compared to other modalities such as radiation, laser, and argon plasma coagulation. They are also the initial treatment of choice for both malignant and benign fistulae. Stents are also used in benign refractory strictures but long-term stricture resolution rates are low in this setting. Fully covered metal stents are relatively easier to remove compared to partially covered stents; optimal time interval for removal depends on the indication for stenting and the clinical status of the patient. Stent related adverse events include chest pain, reflux, migration, and recurrent obstruction. Serious adverse events occur in less than 5% with procedure-related mortality of less than 2%. Techniques such as placement of hemostatic clips, Over The Scope clips, and endoscopic suturing are being used to decrease the migration risk but the optimal approach has not been defined. Antireflux measures are needed when a stent is placed across the gastroesophageal junction. Stents with antireflux designs do not appear to offer additional benefit compared to the conventional stent designs. Newer stent designs including biodegradable, drug eluting and radioactive stents are currently being investigated.

Original languageEnglish (US)
Pages (from-to)155-166
Number of pages12
JournalMinerva Gastroenterologica e Dietologica
Volume62
Issue number2
StatePublished - Jun 1 2016

Fingerprint

Stents
Pathologic Constriction
Deglutition Disorders
Surgical Instruments
Metals
Argon Plasma Coagulation
Esophagogastric Junction
Drug-Eluting Stents
Hemostatics
Esophageal Neoplasms
Chest Pain
Fistula
Anatomy
Lasers
Radiation
Safety
Equipment and Supplies
Mortality

Keywords

  • Deglutition disorders
  • Esophageal neoplasms
  • Esophageal stenosis
  • Fistula
  • Self expandable metallic stents

ASJC Scopus subject areas

  • Gastroenterology
  • Internal Medicine
  • Nutrition and Dietetics
  • Endocrinology, Diabetes and Metabolism

Cite this

Esophageal stents : When and how. / Kachaamy, Toufic; Pannala, Rahul.

In: Minerva Gastroenterologica e Dietologica, Vol. 62, No. 2, 01.06.2016, p. 155-166.

Research output: Contribution to journalReview article

Kachaamy, Toufic ; Pannala, Rahul. / Esophageal stents : When and how. In: Minerva Gastroenterologica e Dietologica. 2016 ; Vol. 62, No. 2. pp. 155-166.
@article{5adfbbcfd30c4a0caf2cd261550a85b6,
title = "Esophageal stents: When and how",
abstract = "Esophageal stents are devices used to alleviate dysphagia and treat leaks and perforations. Successful esophageal stenting requires definition of the abnormal anatomy such as stricture length or location of the leak, proper stent selection and deployment. This requires detailed knowledge of characteristics of the currently available stents. Self-expanding metal stents whether fully or partially covered have become the mainstay of treatment of esophageal cancer-related dysphagia as they provide quick relief of symptoms and have a favorable safety and efficacy profile, compared to other modalities such as radiation, laser, and argon plasma coagulation. They are also the initial treatment of choice for both malignant and benign fistulae. Stents are also used in benign refractory strictures but long-term stricture resolution rates are low in this setting. Fully covered metal stents are relatively easier to remove compared to partially covered stents; optimal time interval for removal depends on the indication for stenting and the clinical status of the patient. Stent related adverse events include chest pain, reflux, migration, and recurrent obstruction. Serious adverse events occur in less than 5{\%} with procedure-related mortality of less than 2{\%}. Techniques such as placement of hemostatic clips, Over The Scope clips, and endoscopic suturing are being used to decrease the migration risk but the optimal approach has not been defined. Antireflux measures are needed when a stent is placed across the gastroesophageal junction. Stents with antireflux designs do not appear to offer additional benefit compared to the conventional stent designs. Newer stent designs including biodegradable, drug eluting and radioactive stents are currently being investigated.",
keywords = "Deglutition disorders, Esophageal neoplasms, Esophageal stenosis, Fistula, Self expandable metallic stents",
author = "Toufic Kachaamy and Rahul Pannala",
year = "2016",
month = "6",
day = "1",
language = "English (US)",
volume = "62",
pages = "155--166",
journal = "Minerva Gastroenterologica",
issn = "0026-4776",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "2",

}

TY - JOUR

T1 - Esophageal stents

T2 - When and how

AU - Kachaamy, Toufic

AU - Pannala, Rahul

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Esophageal stents are devices used to alleviate dysphagia and treat leaks and perforations. Successful esophageal stenting requires definition of the abnormal anatomy such as stricture length or location of the leak, proper stent selection and deployment. This requires detailed knowledge of characteristics of the currently available stents. Self-expanding metal stents whether fully or partially covered have become the mainstay of treatment of esophageal cancer-related dysphagia as they provide quick relief of symptoms and have a favorable safety and efficacy profile, compared to other modalities such as radiation, laser, and argon plasma coagulation. They are also the initial treatment of choice for both malignant and benign fistulae. Stents are also used in benign refractory strictures but long-term stricture resolution rates are low in this setting. Fully covered metal stents are relatively easier to remove compared to partially covered stents; optimal time interval for removal depends on the indication for stenting and the clinical status of the patient. Stent related adverse events include chest pain, reflux, migration, and recurrent obstruction. Serious adverse events occur in less than 5% with procedure-related mortality of less than 2%. Techniques such as placement of hemostatic clips, Over The Scope clips, and endoscopic suturing are being used to decrease the migration risk but the optimal approach has not been defined. Antireflux measures are needed when a stent is placed across the gastroesophageal junction. Stents with antireflux designs do not appear to offer additional benefit compared to the conventional stent designs. Newer stent designs including biodegradable, drug eluting and radioactive stents are currently being investigated.

AB - Esophageal stents are devices used to alleviate dysphagia and treat leaks and perforations. Successful esophageal stenting requires definition of the abnormal anatomy such as stricture length or location of the leak, proper stent selection and deployment. This requires detailed knowledge of characteristics of the currently available stents. Self-expanding metal stents whether fully or partially covered have become the mainstay of treatment of esophageal cancer-related dysphagia as they provide quick relief of symptoms and have a favorable safety and efficacy profile, compared to other modalities such as radiation, laser, and argon plasma coagulation. They are also the initial treatment of choice for both malignant and benign fistulae. Stents are also used in benign refractory strictures but long-term stricture resolution rates are low in this setting. Fully covered metal stents are relatively easier to remove compared to partially covered stents; optimal time interval for removal depends on the indication for stenting and the clinical status of the patient. Stent related adverse events include chest pain, reflux, migration, and recurrent obstruction. Serious adverse events occur in less than 5% with procedure-related mortality of less than 2%. Techniques such as placement of hemostatic clips, Over The Scope clips, and endoscopic suturing are being used to decrease the migration risk but the optimal approach has not been defined. Antireflux measures are needed when a stent is placed across the gastroesophageal junction. Stents with antireflux designs do not appear to offer additional benefit compared to the conventional stent designs. Newer stent designs including biodegradable, drug eluting and radioactive stents are currently being investigated.

KW - Deglutition disorders

KW - Esophageal neoplasms

KW - Esophageal stenosis

KW - Fistula

KW - Self expandable metallic stents

UR - http://www.scopus.com/inward/record.url?scp=84975070015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975070015&partnerID=8YFLogxK

M3 - Review article

C2 - 26824424

AN - SCOPUS:84975070015

VL - 62

SP - 155

EP - 166

JO - Minerva Gastroenterologica

JF - Minerva Gastroenterologica

SN - 0026-4776

IS - 2

ER -